SecBot SecBot
PRESS-RELEASE ·Filed May 18, 2026

IINN

Inspira Technologies
BULLISH
Impact 5/10
Horizonweeks Processed6mo ago WireGlobeNewswire
Press release · Contract
Actionable Insight ▲ Bullish

Monitor for updates on the strategic process involving ART100 monetization; this order provides validation and could enhance deal terms. The reference from NYU Langone may attract additional hospital customers or acquirers.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

BULLISH VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$0.3723
T+0 close · May 18, 2026 · via day close
Latest settled
+245.15%
T+20 · $1.29
Vs SPY
+243.57%
α at T+20
Next horizon
T+60
due 3mo ago
  1. T+0 · May 18 $0.3723entry
  2. T+1 · 6mo ago +2.07%α +2.72% · $0.3800
  3. T+5 · 6mo ago +308.27%α +306.65% · $1.52
  4. T+20 · 5mo ago +245.15%α +243.57% · $1.29
  5. T+60 · due 3mo ago Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Inspira Technologies received a $580,000 commercial purchase order from NYU Langone Hospital for its FDA-cleared ART100 blood circulation systems, following a multi-patient clinical evaluation. The order provides a key reference for ongoing strategic discussions to monetize the ART100 platform and medical assets.

Key Financial Metrics

Revenue
$580.0K
Deal Value
$580.0K

Key Facts

  • $580,000 commercial purchase order from NYU Langone Hospital for ART100 systems
  • Order follows successful clinical evaluation in over 30 patients
  • NYU Langone is a top-ranked academic medical center; provides strong reference for commercial discussions
  • Company is engaged in an active strategic process to potentially monetize the ART100 platform and other medical assets

Financial Impact

$580,000 commercial order for a $17M market cap company; modest but meaningful for a small-cap

revenuecash flow

Risk Factors

  • Order is relatively small ($580k) and may not lead to significant recurring revenue
  • Strategic process may not result in favorable monetization outcomes

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3296515

US Market Status

Market Closed · Opens in 9h 3m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 18, 2026